ESR1 and triple-negative breast carcinoma: Our results demonstrated a strong synergistic effect between Palbociclib and Curcumin in estrogen receptor (ER) positive breast cancer cell line MCF-7 as well as triple-negative breast cancer cell line (TNBC) MDA-MB-231.